
Joe Sanok interviews Kabir Nath about the potential of psilocybin-assisted therapy for treatment-resistant depression.
What happens when traditional depression treatments stop working? Could a single psychedelic-assisted therapy session create lasting change? What does the latest research reveal about psilocybin's potential in mental healthcare? In this episode, Joe Sanok speaks with Compass Pathways CEO Kabir Nath about the emerging role of psilocybin-assisted therapy in treating treatment-resistant depression (TRD). They discuss the latest clinical research, how psychedelic therapy is being studied, and its potential to transform mental healthcare.
Explore listener stats, chart rankings, contacts and more on the The Practice of the Practice Podcast | Where Modern Psychology Meets the Business of Therapy podcast page.